Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
Clinical trial NCT05580445 · UNKNOWN
Trial details
- NCT number
- NCT05580445
- Sponsor
- Shouyao Holdings (Beijing) Co. LTD
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-11
- Primary completion
- 2024-08-11
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.